A New Chapter in Lymphoma Care? AbbVie and Genmab Report 51% Risk Reduction
October 2026, AbbVie and Genmab announced positive topline results from the Phase 3 EPCORE DLBCL-2 trial, which tested Epcoritamab combined with R-CHOP against R-CHOP…
Our Blog
Russian Plague Laboratory Incident: What Is Confirmed, What Plague Is and How It Is Treated
The death of a laboratory worker at a plague research institute in Siberia has drawn international attention to one of history’s most feared infectious…
Rasonque (Daraxonrasib): From FDA Approval to Promising New Directions in Cancer Treatment
The treatment landscape for RAS-driven cancers is entering a new phase. RAS proteins have long been recognised as major drivers of tumour growth, but…
Strait of Hormuz Supply Chain: What UK Wholesalers, Pharmacists and Regulatory Teams Need to Know
A narrow stretch of water between Iran and Oman has become one of the most consequential variables in global medicines logistics. Since late February…
